Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Down 45.6% in December

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANLGet Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 4,639 shares, a decline of 45.6% from the November 30th total of 8,520 shares. Based on an average daily volume of 42,734 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 42,734 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce”.

View Our Latest Research Report on ANL

Adlai Nortye Stock Performance

Shares of ANL opened at $1.64 on Friday. The firm’s fifty day simple moving average is $1.46 and its 200-day simple moving average is $1.57. Adlai Nortye has a twelve month low of $0.88 and a twelve month high of $2.99.

About Adlai Nortye

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

Featured Articles

Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.